Literature DB >> 30360645

Effects of Electronic Cigarette Liquid Flavors and Modified Risk Messages on Perceptions and Subjective Effects of E-Cigarettes.

Rose S Bono1, Andrew J Barnes1, Rebecca C Lester1, Caroline O Cobb1.   

Abstract

Understanding how two characteristics-flavors and modified risk messages-affect perceptions and subjective effects of electronic cigarettes (e-cigarettes) can inform tobacco control efforts. In two within-subjects studies ( N = 17 and N = 19), the effects of e-cigarette flavors (tobacco vs. menthol and unflavored vs. cherry) and hypothetical modified risk messages ("reduced harm relative to cigarettes" vs. no message and "reduced carcinogen exposure relative to cigarettes" vs. no message) on cigarette smokers' perceptions of e-cigarettes were measured after participants self-administered condition-specific products (own-brand cigarettes; e-cigarettes). Perceptions/subjective effects were tested using linear mixed-effects regressions. Cigarettes were perceived as most harmful but rated more positively than e-cigarettes ( ps < .05). Cherry and menthol e-cigarettes increased perceived pleasantness, taste, and physical sensations compared with unflavored and tobacco-flavored e-cigarettes, respectively ( ps < .05). Modified risk messages were associated with reduced ratings of aversive effects ( ps < .05) but not harm perceptions. Overall, few perceptions/subjective effects differed by e-cigarette flavor or message. Flavors and messages may have some influence on how smokers experience e-cigarettes.

Entities:  

Keywords:  e-cigarettes; flavors; modified risk messages; perceptions; subjective effects; tobacco

Mesh:

Substances:

Year:  2018        PMID: 30360645      PMCID: PMC9277700          DOI: 10.1177/1090198118806965

Source DB:  PubMed          Journal:  Health Educ Behav        ISSN: 1090-1981


  14 in total

1.  A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects.

Authors:  Andrea R Vansickel; Caroline O Cobb; Michael F Weaver; Thomas E Eissenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes.

Authors:  Gideon St Helen; Delia A Dempsey; Christopher M Havel; Peyton Jacob; Neal L Benowitz
Journal:  Drug Alcohol Depend       Date:  2017-06-30       Impact factor: 4.492

Review 3.  How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes.

Authors:  Christine D Czoli; Geoffrey T Fong; Darren Mays; David Hammond
Journal:  Tob Control       Date:  2016-09-13       Impact factor: 7.552

4.  Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives.

Authors:  David B Abrams; Allison M Glasser; Jennifer L Pearson; Andrea C Villanti; Lauren K Collins; Raymond S Niaura
Journal:  Annu Rev Public Health       Date:  2018-01-11       Impact factor: 21.981

5.  E-cigarette Use Among US Adults: Population Assessment of Tobacco and Health (PATH) Study.

Authors:  Brad Rodu; Nantaporn Plurphanswat
Journal:  Nicotine Tob Res       Date:  2018-07-09       Impact factor: 4.244

6.  Beliefs and experimentation with electronic cigarettes: a prospective analysis among young adults.

Authors:  Kelvin Choi; Jean L Forster
Journal:  Am J Prev Med       Date:  2014-02       Impact factor: 5.043

7.  Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2016-05-10

8.  The impact of flavoring on the rewarding and reinforcing value of e-cigarettes with nicotine among young adult smokers.

Authors:  Janet Audrain-McGovern; Andrew A Strasser; E Paul Wileyto
Journal:  Drug Alcohol Depend       Date:  2016-07-01       Impact factor: 4.492

9.  Smokers' and e-cigarette users' perceptions of modified risk warnings for e-cigarettes.

Authors:  Olivia A Wackowski; Richard J O'Connor; Andrew A Strasser; David Hammond; Andrea C Villanti; Cristine D Delnevo
Journal:  Prev Med Rep       Date:  2016-07-10

10.  Effect of Flavors and Modified Risk Messages on E-cigarette Abuse Liability.

Authors:  Andrew J Barnes; Rose S Bono; Rebecca C Lester; Thomas E Eissenberg; Caroline O Cobb
Journal:  Tob Regul Sci       Date:  2017-10
View more
  5 in total

1.  Journal Club-Electronic Cigarettes and Vaping as a Harm Reduction Alternative: Really?

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2019-07-24

2.  The Impact of E-liquid Propylene Glycol and Vegetable Glycerin Ratio on Ratings of Subjective Effects, Reinforcement Value, and Use in Current Smokers.

Authors:  Tracy T Smith; Bryan W Heckman; Amy E Wahlquist; K Michael Cummings; Matthew J Carpenter
Journal:  Nicotine Tob Res       Date:  2020-04-21       Impact factor: 4.244

3.  Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers.

Authors:  Adam M Leventhal; Nicholas I Goldenson; Jessica L Barrington-Trimis; Raina D Pang; Matthew G Kirkpatrick
Journal:  Drug Alcohol Depend       Date:  2019-08-01       Impact factor: 4.492

4.  Preferred flavors and tobacco use patterns in adult dual users of cigarettes and ENDS.

Authors:  Eva C Rest; Kristin N Brikmanis; Robin J Mermelstein
Journal:  Addict Behav       Date:  2021-10-30       Impact factor: 3.913

5.  The Role of Nicotine and Flavor in the Abuse Potential and Appeal of Electronic Cigarettes for Adult Current and Former Cigarette and Electronic Cigarette Users: A Systematic Review.

Authors:  Mari S Gades; Aleksandra Alcheva; Amy L Riegelman; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2022-08-06       Impact factor: 5.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.